Clin2
NCT07788053Likely a fitNot yet recruiting

A three-drug treatment for H. pylori infection

Helicobatcer PyloriFirst-Line Eradication

Treatments studied

This study tests a three-medicine combination (bismuth, tetracycline, and rabeprazole) as a first treatment to get rid of an H. pylori infection, a common stomach bacteria that can cause ulcers and other problems. The aim is to see if this treatment works well and is safe, so it might help you clear the infection and improve your stomach health.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
300 people
Ages
18 years to 90 years
Study type
Interventional

Who can take part

  • You are 18 years or older
  • You have been tested and confirmed to have an H. pylori infection (via a quick test or tissue sample from an endoscopy)
  • You have not had treatment for H. pylori before
  • You have not had your stomach removed (no gastrectomy)
  • You are not allergic to any of the study medications (bismuth, tetracycline, rabeprazole)
  • You have not taken any antibiotics in the last 4 weeks
  • You will be able to come back for a follow-up test to see if the infection is gone

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06509139Enrolling by invitation· Phase 4
Finding the best treatment length for H. pylori infection

This study tests how long (10 or 14 days) a combination of four medicines (bismuth quadruple therapy) should be taken to best treat H. pylori infection, and whether the best duration differs between women and men. It aims to find the shortest effective treatment to reduce side effects.

Tainan
NCT07142798Enrolling by invitation
14-day triple therapy for H. pylori infection

This trial tests a 14-day treatment using bismuth, amoxicillin, and a stomach acid reducer (PCAB) to see how well it clears H. pylori, a bacteria that can cause stomach ulcers. It may be an option if you have H. pylori and haven't had stomach surgery or certain serious health conditions.

Kaohsiung City
NCT06349486Recruiting
Comparing new treatments for H. pylori infection

This trial compares three different medication combinations to see which works best for treating H. pylori infection. If you have H. pylori and haven't been treated yet, you may be able to join.

Kaohsiung City
NCT07285096Recruiting
New quadruple therapy for H. pylori infection

This trial tests a combination of four medications to treat H. pylori, a bacteria that can cause stomach ulcers and other issues. The goal is to see if this newer therapy works well for people who are infected.

Jinan
NCT06731023Not yet recruiting
Treating Stubborn H. pylori with Tailored Bismuth Quadruple Therapy

This study tests whether a 14-day treatment with bismuth and four drugs, chosen based on lab tests showing which antibiotics still work, can clear an extremely stubborn H. pylori infection that hasn't gone away after at least two prior treatments.

Jinan, Shandong
NCT07115173Not yet recruiting· Phase 4
Triple therapy study for H. pylori infection

This study tests a triple therapy drug combination to treat Helicobacter pylori (H. pylori), a bacteria that can cause stomach problems. It may help people with certain stomach conditions who need to get rid of the infection.

Hear when a new Helicobatcer Pylori trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.